ATE320497T1 - An die periplasmatische membran gebundenes system zur ermittlung von protein-protein interaktionen - Google Patents

An die periplasmatische membran gebundenes system zur ermittlung von protein-protein interaktionen

Info

Publication number
ATE320497T1
ATE320497T1 AT94114325T AT94114325T ATE320497T1 AT E320497 T1 ATE320497 T1 AT E320497T1 AT 94114325 T AT94114325 T AT 94114325T AT 94114325 T AT94114325 T AT 94114325T AT E320497 T1 ATE320497 T1 AT E320497T1
Authority
AT
Austria
Prior art keywords
ligand
fusion protein
binding
reporter gene
protein
Prior art date
Application number
AT94114325T
Other languages
English (en)
Inventor
Rolf Menzel
Scott T Taylor
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ATE320497T1 publication Critical patent/ATE320497T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/71—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16
    • C07K2319/715—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16 containing a domain for ligand dependent transcriptional activation, e.g. containing a steroid receptor domain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/73—Fusion polypeptide containing domain for protein-protein interaction containing coiled-coiled motif (leucine zippers)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
AT94114325T 1993-09-13 1994-09-12 An die periplasmatische membran gebundenes system zur ermittlung von protein-protein interaktionen ATE320497T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/121,201 US5521066A (en) 1993-09-13 1993-09-13 Periplasmic membrane-bound system for detecting protein-protein interactions

Publications (1)

Publication Number Publication Date
ATE320497T1 true ATE320497T1 (de) 2006-04-15

Family

ID=22395200

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94114325T ATE320497T1 (de) 1993-09-13 1994-09-12 An die periplasmatische membran gebundenes system zur ermittlung von protein-protein interaktionen

Country Status (7)

Country Link
US (2) US5521066A (de)
EP (1) EP0646644B1 (de)
JP (1) JP3527288B2 (de)
AT (1) ATE320497T1 (de)
CA (1) CA2117612C (de)
DE (1) DE69434661T2 (de)
ES (1) ES2260755T3 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4319296A1 (de) * 1993-06-10 1994-12-15 Behringwerke Ag Genetische Selektion von zur Ligandenbindung befähigten Proteinen mittels Signaltransduktion in Mikroorganismen
CA2184356A1 (en) * 1994-03-03 1995-09-08 Russell P. Rother Terminal complement inhibitor fusion genes and proteins
US8349602B1 (en) * 1996-04-19 2013-01-08 Xenogen Corporation Biodetectors targeted to specific ligands
US6265174B1 (en) 1997-11-03 2001-07-24 Morphochem, Inc. Methods and compositions for identifying and modulating ctionprotein-interactions
CA2331258C (en) 1998-06-12 2011-09-20 Henry M. Jackson Foundation For The Advancement Of Military Medicine Enhancement of b cell activation and immunoglobulin secretion by co-stimulation of receptors for antigen and ebv gp350/220
EP1101112B1 (de) * 1998-07-28 2004-10-06 Vlaams Interuniversitair Instituut voor Biotechnologie vzw. Leptin vermittelte geninduktion
US6210924B1 (en) 1998-08-11 2001-04-03 Amgen Inc. Overexpressing cyclin D 1 in a eukaryotic cell line
EP1283878B1 (de) * 2000-05-22 2005-07-27 Vlaams Interuniversitair Instituut voor Biotechnologie vzw. Auf rezeptorgrundlage arbeitende screening-verfahren für protein wechselwirkungen
US7094571B2 (en) * 2000-10-27 2006-08-22 The Board Of Regents Of The University Of Texas System Combinatorial protein library screening by periplasmic expression
US7083945B1 (en) 2000-10-27 2006-08-01 The Board Of Regents Of The University Of Texas System Isolation of binding proteins with high affinity to ligands
ATE497603T1 (de) 2001-03-02 2011-02-15 Gpc Biotech Ag Drei-hybrid-assaysystem
EP1578914A2 (de) * 2001-09-12 2005-09-28 Pharmacia & Upjohn Company LLC Menschliche ionenkanäle
WO2003040385A2 (en) * 2001-11-06 2003-05-15 Mcgill University Membrane protein interaction assays
US7611866B2 (en) * 2002-07-15 2009-11-03 Board Of Regents, The University Of Texas System Selection of bacterial inner-membrane anchor polypeptides
CA2560074A1 (en) * 2004-03-18 2005-11-03 Board Of Regents, The University Of Texas System Combinatorial protein library screening by periplasmic expression
EP1812038A1 (de) * 2004-11-18 2007-08-01 VIB vzw Fibronectin iii domäne als leptin-rezeptor-antagonisten
EP4069731A4 (de) 2019-12-03 2024-05-29 Alamar Biosciences, Inc. Nukleinsäure-gekoppelter immun-sandwich-assay (nulisa)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4774182A (en) * 1984-06-29 1988-09-27 Wisconsin Alumni Research Foundation Partially defective foreign gene for conferring immunity on a biological host
SE8605621D0 (sv) * 1986-12-30 1986-12-30 Biokonsult Ab Heteromultimeric proteins and their manufacture
FR2621597B1 (fr) * 1987-07-24 1992-07-31 Pasteur Institut Procede de clonage et d'expression de genes codant pour des proteines constituant des edifices fonctionnels organises
GB8807683D0 (en) * 1988-03-31 1988-05-05 Ici Plc Regulation of gene expression
EP0528827B1 (de) * 1990-04-19 1996-09-04 The General Hospital Corporation Screening nach proteinpartnern und deren verwendung
AU8059891A (en) * 1990-06-13 1992-01-07 Trustees Of Princeton University, The A (lac) repressor-hsv vp16 chimeric transcriptional activator protein system functioning in transfected mammalian cells
US5219990A (en) * 1991-01-28 1993-06-15 Biogen, Inc. Papillomavirus e2 trans-activation repressors
EP0575410B1 (de) * 1991-03-07 1999-05-19 BRADBURY, Andrew Raymon Morton Auswahl spezifischer proteine durch ein biologisches verfahren
DE4319296A1 (de) * 1993-06-10 1994-12-15 Behringwerke Ag Genetische Selektion von zur Ligandenbindung befähigten Proteinen mittels Signaltransduktion in Mikroorganismen

Also Published As

Publication number Publication date
EP0646644B1 (de) 2006-03-15
JPH07250689A (ja) 1995-10-03
DE69434661T2 (de) 2006-12-07
JP3527288B2 (ja) 2004-05-17
ES2260755T3 (es) 2006-11-01
EP0646644A2 (de) 1995-04-05
US5521066A (en) 1996-05-28
CA2117612A1 (en) 1995-03-14
US5744314A (en) 1998-04-28
EP0646644A3 (de) 1996-07-10
DE69434661D1 (de) 2006-05-11
CA2117612C (en) 2008-12-30

Similar Documents

Publication Publication Date Title
ATE320497T1 (de) An die periplasmatische membran gebundenes system zur ermittlung von protein-protein interaktionen
Takemori et al. Two types of mu chain complexes are expressed during differentiation from pre‐B to mature B cells.
WO2000012708A3 (en) Further pro polypeptides and sequences thereof
ATE365325T1 (de) Screening von kombinatorischen peptidbibliotheken zur selektion von peptidliganden zur verwendung in der affinitätsreinigung von zielproteinen
NL300153I1 (nl) Voor Factor VIIIC coderende DNA-sequenties en verwante DNA-constructen.
DE69835143D1 (de) Selektion von proteinen mittels rns-protein fusionen
ATE522610T1 (de) Menschliche, metabotrope glutamatrezeptor- subtypen (hmr6) und verwandte dns-verbindungen
ATE172247T1 (de) Car-rezeptoren und verwandte moleküle und entsprechende methoden
Gershoni Emerging techniques: Protein blotting: developments and perspectives
DK0845005T3 (da) TRAF-inhibitorer
DE69435020D1 (en) Protein-tyrosin-phosphatase ptp-s31
DE69533777D1 (de) Mit retenoid x-rezeptor interagierende polypeptide und verwandte moleküle und verfahren
Necina et al. Peptide affinity chromatography of human clotting factor VIII: Screening of the vWF-binding domain
ATE462721T1 (de) Breit einsetzbares verfahren zur identifizierung von modulatoren von g-protein gekoppelten rezeptoren
US12509500B2 (en) Composition comprising recombinant Gplbα receptor protein
DE69316388D1 (de) CRF Bindungsproteine
US20190194249A1 (en) Polypeptide exhibiting affinity to antibodies forming non-native three-dimensional structure
DE60129719D1 (de) Screening-verfahren zum identifizieren von g-proteinen und anderen verbindungen,die die phosphodiesterase (pde)-aktivität beeinflussen
Schröder et al. Identification of a novel platelet-derived neutrophil-chemotactic polypeptide with structural homology to platelet-factor 4
US20050153383A1 (en) Synthetic and recombinant substrates for the detecion of the von willebrand factor-cleaving protease
DE3855007D1 (de) METHODE ZUR REINIGUNG REKOMBINANTER t-PA VON DEN IHREN ENTSPRECHENDEN WIRTSZELLPROTEINEN
Anaya et al. A multiplex extracellular interactome screening method employing high-avidity nanoparticles
DK0726951T3 (da) Fremstilling og anvendelse af polypeptider påhæftet tag under anvendelse af bindende molekyler
WO2000075362A3 (en) Method for identifying novel transcriptional regulatory proteins
JPWO2004022599A1 (ja) 融合抗体及びその作成方法

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0646644

Country of ref document: EP

REN Ceased due to non-payment of the annual fee